| Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single … O Al-Asadi, M Almusarhed, H Eldeeb Thrombosis journal 17, 1-7, 2019 | 86 | 2019 |
| Solitary biceps muscle metastasis from breast cancer M Almusarhed, H Eldeeb Case Reports 2017, bcr-2017-220597, 2017 | 12 | 2017 |
| Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen O Al-Asadi, M Almusarhed, SAJ Rizvi, W Saka ecancermedicalscience 12, 2018 | 2 | 2018 |
| Osimertinib in untreated EGFR-mutated advanced lung adenocarcinoma: real world data M Almusarhed, F Rehman, R Chen, S Ahmed Lung Cancer 178, S33, 2023 | | 2023 |
| Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data HC Younan, S Zhang, M Monroy, M Almusarhed, M Julve, D Roy, ... Lung Cancer 165, S32, 2022 | | 2022 |
| EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) with EGFR activating mutations–real world data S Dulloo, M Almusarhed, R Chen, O Akala, B Varadhan, M Chauhan, ... Lung Cancer 156, S40, 2021 | | 2021 |
| Comparison between 1st generation EGFR tyrosine kinase inhibitor (gefitinib) versus 2nd generation (afatinib) in EGFR-mutated non-small cell lung cancers (NSCLC)–real world … S Dulloo, M Almusarhed, R Chen, O Akala, B Varadhan, M Chauhan, ... Lung Cancer 156, S42-S43, 2021 | | 2021 |
| Assessment of the role of the preoperative neutrophil-lymphocyte ratio as a prognostic biomarker in nonmetastatic rectal cancer HE Manar Almusarhed,Osamah Al-Asadi,Azhar Rizvi,Anil Hermanad,Qamar Zaman ... NCRI Cancer Conference, 2019 | | 2019 |
OSAMAH AL-ASADIDrVerified email at buckingham.ac.uk
OSAMAH AL-ASADIDrVerified email at buckingham.ac.uk